Gestational diabetes can be tip-off to future increased risk for heart disease
Kaiser Permanente research shows 2-fold higher risk for heart artery calcification after pregnancy through mid-life, even in women with normal blood sugar levels.
Heart failure hospitalizations and deaths vary by race and ethnicity
Black patients with heart failure have higher rates of hospitalization for heart failure but lower rates of death than white patients with heart failure, a new Kaiser Permanente study shows.
5 Questions for . . . Anjali Gopalan
Research scientist uses her experiences as a physician to design studies that focus on and can improve care for people with early-onset type 2 diabetes.
Kaiser Permanente data key to nation’s COVID-19 vaccine surveillance strategy
Kaiser Permanente’s Vaccine Study Center is leading a key part of the national safety surveillance effort for the COVID-19 vaccines, tracking patient data for serious side effects.
Long-term exposure to air pollution increases risk of dying from heart disease and stroke
New study is first to quantify and compare the effects of long-term exposure to small particle pollution on risk for different types of cardiovascular disease.
Pediatrician screening of young people with substance use, mood problems can have long-term results
Adolescents who had access to a brief intervention and referral to treatment for substance use or mood problems at a pediatric clinic were less likely to have a related diagnosis 3 years later, new Kaiser Permanente research finds.
Exercising more in early pregnancy may reduce gestational diabetes risk
Pregnant women who exercised more during the first trimester of pregnancy had a lower risk of developing gestational diabetes, a new analysis of Kaiser Permanente data finds.
Unique genetic factors and ancestry, along with lifestyle, influence skin cancer risk
People can look to the Northern European side of their genetic heritage for increased risk of nonmelanoma skin cancer, according to the first large analysis of genetic risk factors for cutaneous squamous cell carcinoma in diverse populations with European ancestry from Kaiser Permanente researchers.
Gaining insight into medically complex patients
New Kaiser Permanente study aims to help providers improve the health of patients most likely to sustain high medical costs, frequently use the emergency department, or need to be hospitalized.
Kaiser Permanente to study statins’ effect on Alzheimer’s disease and related dementias
The potential for statins — a widely prescribed class of cholesterol-lowering medication — to reduce the risk of Alzheimer’s disease and related dementias will be explored in a 4-year study led by Division of Research investigator Catherine Schaefer, PhD.
